Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,630 total articles

S&P Global Ratings Upgrades Teva to BBB-, Marking Third Credit Rating Upgrade in Recent Months and Reflecting Strong Execution and Financial Discipline

S&P Global Ratings Upgrades Teva to BBB-, Marking Third Credit Rating Upgrade in Recent Months and Reflecting Strong Execution and Financial Discipline

Teva Pharmaceutical Industries Ltd. announced that S&P Global Ratings has upgraded its long-term issuer credit rating from BB+ to BBB-, marking the third credit upgrade in recent months from major rating agencies. This upgrade reflects Teva's strong execution of its Pivot to Growth strategy, significant debt reduction, and financial strengthening, …

Hawthorn Bancshares, Inc. Completes Merger with FSC Bancshares, Inc.

Hawthorn Bancshares, Inc. Completes Merger with FSC Bancshares, Inc.

Hawthorn Bancshares, Inc. has finalized its merger with FSC Bancshares, Inc., integrating Farmers State Bank into Hawthorn Bank. The combined entity now holds approximately $2.2 billion in total assets and operates 27 locations across Missouri and one in Kansas. The merger aims to enhance financial solutions and community banking services for custo…

SoundHound AI Completes Acquisition of LivePerson, Creating a World-Leading Omnichannel Conversational AI Powerhouse

SoundHound AI Completes Acquisition of LivePerson, Creating a World-Leading Omnichannel Conversational AI Powerhouse

SoundHound AI has completed its acquisition of LivePerson, expanding its market footprint and customer base, including 25 of the Fortune 100. The acquisition integrates LivePerson's digital messaging infrastructure with SoundHound’s voice agentic AI platform, OASYS, creating a unified conversational AI solution across multiple channels. The combine…

Imperial Petroleum Inc. Announces the Date for the Release of the Second Quarter and Six Months 2026 Financial and Operating Results, Conference Call and Webcast

Imperial Petroleum Inc. Announces the Date for the Release of the Second Quarter and Six Months 2026 Financial and Operating Results, Conference Call and Webcast

Imperial Petroleum Inc., a Nasdaq-listed ship-owning company specializing in petroleum products and drybulk seaborne transportation services, announced it will release its financial and operating results for Q2 and the first half of 2026 on September 10, followed by a conference call and webcast. The company currently operates 21 vessels with plans…

Integra LifeSciences to Present at the 2026 Wells Fargo Healthcare Conference and the 2026 Morgan Stanley Healthcare Conference

Integra LifeSciences to Present at the 2026 Wells Fargo Healthcare Conference and the 2026 Morgan Stanley Healthcare Conference

Integra LifeSciences Holdings Corporation will present at the 2026 Wells Fargo Healthcare Conference and the 2026 Morgan Stanley Healthcare Conference, showcasing its leadership team and company vision to investors and industry professionals. Live webcasts of the presentations will be available on the company's investor relations website.

Bilibili Inc. Announces Pricing of Offerings of US$700 Million Convertible Senior Notes, Concurrent Equity Placement and Concurrent Share Repurchases

Bilibili Inc. Announces Pricing of Offerings of US$700 Million Convertible Senior Notes, Concurrent Equity Placement and Concurrent Share Repurchases

Bilibili Inc. announced the pricing of $700 million convertible senior notes due 2031, including a $200 million subscription by Tencent. Concurrently, Bilibili is conducting a fixed-price equity placement and share repurchases totaling up to $300 million. Proceeds will fund AI-driven growth initiatives and general corporate purposes. The initiative…

DeFi Development Corp. Announces Pricing of Initial Public Offering of Variable Rate Series C Perpetual Preferred Stock

DeFi Development Corp. Announces Pricing of Initial Public Offering of Variable Rate Series C Perpetual Preferred Stock

DeFi Development Corp. announced the pricing of its IPO of 1,375,000 shares of Variable Rate Series C Perpetual Preferred Stock at $8 per share, targeting gross proceeds of approximately $11 million. The company plans to use the net proceeds to acquire Solana (SOL) and other digital asset investments, support strategic transactions, and fuel growth…

Pilgrim’s Pride Announces Offering of Senior Notes

Pilgrim’s Pride Announces Offering of Senior Notes

Pilgrim’s Pride Corporation and its wholly owned subsidiary Pilgrim’s Europe Finance plc have initiated a private offering of up to €500 million aggregate principal of senior notes. The proceeds will be used for general corporate purposes, including financing the recently announced acquisition of Walkers Deli & Sausage Company and covering related …

Nanox Signs Distribution Agreement with Associated X-Ray Imaging to Expand Nanox.ARC Adoption Across New England

Nanox Signs Distribution Agreement with Associated X-Ray Imaging to Expand Nanox.ARC Adoption Across New England

Nano-X Imaging Ltd. (NASDAQ: NNOX) announced a new distribution agreement between its U.S. subsidiary, Nanox Impact Inc., and Associated X-Ray Imaging Corp., a leading New England medical imaging provider. This partnership will leverage Associated X-Ray's regional presence to market, distribute, and support Nanox's FDA-cleared digital 3D tomosynthe…

Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care

Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care

Tarsus Pharmaceuticals has completed its acquisition of Alkeus Pharmaceuticals, gaining worldwide rights to ALK-001, a Phase 3 investigational oral drug targeting Stargardt disease, a rare retinal disorder with no FDA-approved treatments. ALK-001 has several FDA designations including Breakthrough Therapy and Orphan Drug, and topline Phase 3 data f…

Virco Reports Revenue through Six Months Declined 6.1% to $118.2 Million from $125.8 Million, as Rebalancing of School Furniture Market Continues

Virco Reports Revenue through Six Months Declined 6.1% to $118.2 Million from $125.8 Million, as Rebalancing of School Furniture Market Continues

Virco Mfg. Corporation reported a 6.1% decline in revenue through the first six months of 2026 to $118.2 million, reflecting ongoing market rebalancing in the school furniture sector. Despite lower sales, the company maintained strong operating income above its long-term average and declared a quarterly dividend. Recent budget approvals in public s…

Iovance Biotherapeutics to Present at Upcoming Conferences

Iovance Biotherapeutics to Present at Upcoming Conferences

Iovance Biotherapeutics, a biotechnology company specializing in tumor infiltrating lymphocyte (TIL) therapies for cancer, announced that its senior leadership will present at the Wells Fargo 21st Annual Healthcare Conference and the H.C. Wainwright 28th Annual Global Investment Conference. These presentations are part of the company's ongoing effo…

QikBIM Goes Viral: OFA Group’s AI-Powered BIM Platform Surges Past 281,000 Views and Adds Thousands of New Followers in 90 Days, Converts First Paying Subscribers and Targets Over $1 Million in Savings Per Project

QikBIM Goes Viral: OFA Group’s AI-Powered BIM Platform Surges Past 281,000 Views and Adds Thousands of New Followers in 90 Days, Converts First Paying Subscribers and Targets Over $1 Million in Savings Per Project

OFA Group (Nasdaq: OFAL) announced that its AI-powered Building Information Modeling platform, QikBIM, has rapidly gained over 281,000 views and thousands of new followers within 90 days of launch. The platform reached nearly 187,000 architecture, engineering, and construction professionals in an eight-day paid campaign, significantly exceeded indu…

Alumis to Participate in Upcoming September Investor Conferences

Alumis to Participate in Upcoming September Investor Conferences

Alumis Inc., a late-stage biopharmaceutical company specializing in next-generation targeted therapies for immune-mediated diseases, announced its participation in several prominent investor conferences throughout September 2026. The company plans to present updates on its pipeline, including oral TYK2 inhibitors envudeucitinib and A-005, targeting…

Hurco Reports Profit in Third Quarter Results for Fiscal Year 2026

Hurco Reports Profit in Third Quarter Results for Fiscal Year 2026

Hurco Companies, Inc. reported a net income of $2.314 million for Q3 fiscal 2026, a significant turnaround from a net loss in the same period last year. Sales increased 3% year-over-year, driven by higher machine sales in the U.S. and Asia Pacific regions and a stronger product mix. Gross margin expanded by 800 basis points to 28%, aided by cost co…